Author:
Newman Mary B.,Freeman Thomas B.,Davis Cyndy D.,Sanberg Paul R.
Publisher
Kluwer Academic Publishers
Reference164 articles.
1. Andrews PW, Damjanov I, Simon D, Banting GS, Carlin C, Dracopoli NC, Fogh J (1984) Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line Tera-2. Differentiation in vivo and in vitro. Lab Invest 50:147–162.
2. Akerud P, Canals JM, Snyder EY, Arenas E (2001) Neuroprotection through delivery of glial cell line-derived neurotrophic factor by neural stem cells in a mouse model of Parkinson’s disease. J Neurosci 21:8108–8118.
3. Akiyama Y, Honmou O, Kato T, Uede T, Hashi K, Kocsis JD (2001) Transplantation of clonal neural precursor cells derived from adult human brain establishes functional peripheral myelin in the rat spinal cord. Exp Neurol 167:27–39.
4. Arenas E (2002) Stem cells in the treatment of Parkinson’s disease. Brain Res Bull 57:795–808.
5. Bachoud-Levi AC, Bourdet C, Brugieres P, N’Guyen JP, Grandmougin T, Haddad B, Jeny R, Bartolomeo P, Boisse MF, Dall Barba G, Degos JD, Ergis AM, Lefaucheur JP, Lisovoski F, Pailhous E, Remy P, Palfi S, Defer G, Cesaro P, Hantraye P, Peschanski M (1999) Safety and tolerability assessment of intrastriatal neural allografts in five patients with Huntington’s disease. Experimental Neurology 161:194–202.